Crononutrição como estratégia dietoterápica adjuvante no tratamento do Diabetes Mellitus tipo 2: uma revisão integrativa da literatura
DOI:
https://doi.org/10.34117/bjdv12n8-004Keywords:
Diabetes mellitus tipo 2, crononutrição, jejum intermitente, time-restricted eating, dietoterapiaAbstract
O Diabetes Mellitus tipo 2 (DM2) é uma doença metabólica caracterizada por resistência à insulina, disfunção das células beta pancreáticas e associação com obesidade, sedentarismo, alterações do sono e desregulação circadiana. Nesse contexto, a crononutrição tem ganhado destaque por avaliar a influência do horário das refeições e dos ritmos biológicos sobre o metabolismo. Foi realizada uma revisão integrativa da literatura na base PubMed, incluindo estudos publicados entre 2016 e 2026. Este trabalho analisou o impacto de estratégias como alimentação com restrição temporal e jejum intermitente no manejo do DM2. Foram incluídos 14 estudos, totalizando 1.365 participantes, que demonstraram benefícios sobre HbA1c, glicemia de jejum, peso corporal, resistência à insulina, perfil lipídico, pressão arterial e uso de medicamentos, além de boa segurança e adesão. Assim, estratégias nutricionais baseadas no tempo apresentam potencial como abordagens complementares no DM2, podendo ser aplicadas de forma individualizada conforme as características e necessidades dos pacientes.
References
- ZHOU, B. et al. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. The Lancet, v. 404, n. 10467, p. 2077–2093, 2024. Disponível em: https://doi.org/10.1016/S0140-6736(24)02317-1.
- MALTA, D. C. et al. Prevalence of diabetes mellitus as determined by glycated hemoglobin in the Brazilian adult population, national health survey. Revista Brasileira de Epidemiologia, v. 22, 2019. Disponível em: https://doi.org/10.1590/1980-549720190006.supl.2.
- BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Departamento de Análise Epidemiológica e Vigilância de Doenças Não Transmissíveis. Vigitel Brasil 2023: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. Brasília: Ministério da Saúde, 2023. Disponívelem:http://bvsms.saude.gov.br/bvs/publicacoes/vigitel_brasil_2023.pdf. Acesso em: 25 jun. 2026.
- KALYANI, R. R. et al. Diagnosis and treatment of type 2 diabetes in adults: a review. JAMA, Chicago, v. 334, n. 11, p. 984–1002, 2025. Disponível em: https://doi.org/10.1001/jama.2025.5956. Acesso em: 29 jun. 2026.
- HU, S. et al. Risk factors for progression to type 2 diabetes in prediabetes: a systematic review and meta-analysis. BMC Public Health, v. 25, n. 1, p. 1220, 2025. Disponível em: https://doi.org/10.1186/s12889-025-21404-4.
- FRANZAGO, M. et al. Chrono-Nutrition: Circadian Rhythm and Personalized Nutrition. International Journal of Molecular Sciences, v. 24, n. 3, 2023. MDPI. Disponível em: https://doi.org/10.3390/ijms24032571.
- OIKE, H.; OISHI, K.; KOBORI, M. Nutrients, Clock Genes, and Chrononutrition. Current Nutrition Reports, v. 3, n. 3, p. 204–212, 2014. Current Science Inc. Disponível em: https://doi.org/10.1007/s13668-014-0082-6.
- HENRY, C. J.; KAUR, B.; QUEK, R. Y. C. Chrononutrition in the management of diabetes. Nutrition and Diabetes, v. 10, n. 1, 2020. Springer Nature. Disponível em: https://doi.org/10.1038/s41387-020-0109-6.
- PAPAKONSTANTINOU, E. et al. Effects of Diet, Lifestyle, Chrononutrition and Alternative Dietary Interventions on Postprandial Glycemia and Insulin Resistance. Nutrients, v. 14, n. 4, 2022. MDPI. Disponível em: https://doi.org/10.3390/nu14040823.
- PAGE, M. J. et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, v. 372, 2021. BMJ Publishing Group. Disponível em: https://doi.org/10.1136/bmj.n71.
- ZHUANG, P. et al. Marine n-3 polyunsaturated fatty acids slow sleep impairment progression by regulating central circadian rhythms in type 2 diabetes. Cell Reports Medicine, v. 6, n. 5, 2025. Disponível em: https://doi.org/10.1016/j.xcrm.2025.102128.
- GUO, L. et al. A 5:2 Intermittent Fasting Meal Replacement Diet and Glycemic Control for Adults with Diabetes: The EARLY Randomized Clinical Trial. JAMA Network Open, v. 7, n. 6, p. e2416786, 2024. Disponível em: https://doi.org/10.1001/jamanetworkopen.2024.16786.
- YANG, X. et al. Effect of an Intermittent Calorie-restricted Diet on Type 2 Diabetes Remission: A Randomized Controlled Trial. Journal of Clinical Endocrinology and Metabolism, v. 108, n. 6, p. 1415–1424, 2023. Disponível em: https://doi.org/10.1210/clinem/dgac661.
- OBERMAYER, A. et al. Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial. Diabetes Care, v. 46, n. 2, p. 463–468, 2023. Disponível em: https://doi.org/10.2337/dc22-1622.
- DIONNE, V. et al. Optimizing cardiovascular health with a type 2 diabetes remission program: Ultraprocessed food-intake reduction, Mediterranean diet, chrononutrition and physical training—The DIABEPIC-2 pilot study. Diabetes, Obesity and Metabolism, v. 27, n. 12, p. 7374–7384, 2025. Disponível em: https://doi.org/10.1111/dom.70142.
- ABDEL FATTAH, S. M. et al. The impact of intermittent fasting during weight reduction in people living with type 2 diabetes mellitus: a randomized clinical trial. European Journal of Clinical Nutrition, 2026. Disponível em: https://doi.org/10.1038/s41430-025-01693-z.
- KRAMER, C. K. et al. Effect of Time-Restricted Eating on β-Cell Function in Adults With Type 2 Diabetes. Journal of Clinical Endocrinology and Metabolism, v. 110, n. 6, p. e2045–e2053, 2025. Disponível em: https://doi.org/10.1210/clinem/dgae594.
- SUKKRIANG, N.; BURANAPIN, S. Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial. Journal of Diabetes Investigation, v. 15, n. 9, p. 1297–1305, 2024. Disponível em: https://doi.org/10.1111/jdi.14186.
- ANDRIESSEN, C. et al. Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial. Diabetologia, 2022. Disponível em: https://doi.org/10.1007/s00125-022-05752-z.
- PARR, E. B. et al. Comparing the effects of time-restricted eating on glycaemic control in people with type 2 diabetes with standard dietetic practice: A randomised controlled trial. Diabetes Research and Clinical Practice, v. 217, 2024. Disponível em: https://doi.org/10.1016/j.diabres.2024.111893.
- TRICÒ, D. et al. Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes: a randomised controlled trial. Diabetologia, v. 67, n. 2, p. 263–274, 2024. Disponível em: https://doi.org/10.1007/s00125-023-06045-9.
- BRAVO-GARCIA, A. P. et al. Combined effects of time-restricted eating and exercise on short-term blood glucose management in individuals with Type 2 Diabetes Mellitus: The TREx study, a randomised controlled trial. Diabetes Research and Clinical Practice, v. 222, 2025. Disponível em: https://doi.org/10.1016/j.diabres.2025.112081.
- PAMMER, A. et al. Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial. Cardiovascular Diabetology, v. 23, n. 1, 2024. Disponível em: https://doi.org/10.1186/s12933-024-02426-5.
- PAVLOU, V. et al. Effect of Time-Restricted Eating on Sleep in Type 2 Diabetes. Nutrients, v. 16, n. 16, 2024. Disponível em: https://doi.org/10.3390/nu16162742.
- SCHRADER, L. A. et al. Circadian disruption, clock genes, and metabolic health. The Journal of Clinical Investigation, v. 134, n. 14, p. e170998, 2024. Disponível em: https://doi.org/10.1172/JCI170998.
- MELÉNDEZ-FERNÁNDEZ, O. H.; LIU, J. A.; NELSON, R. J. Circadian Rhythms Disrupted by Light at Night and Mistimed Food Intake Alter Hormonal Rhythms and Metabolism. International Journal of Molecular Sciences, v. 24, n. 4, p. 3392, 2023. Disponível em: https://doi.org/10.3390/ijms24043392.
- SPEKSNIJDER, E. M. et al. Circadian desynchrony and glucose metabolism. Journal of Pineal Research, v. 76, n. 4, p. e12956, 2024. Disponível em: https://doi.org/10.1111/jpi.12956.
- JOUFFE, C. et al. Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease. Proceedings of the National Academy of Sciences of the United States of America, v. 119, n. 10, p. e2200083119, 2022. Disponível em: https://doi.org/10.1073/pnas.2200083119.
- LU, L. et al. The effect of intermittent fasting on insulin resistance, lipid profile, and inflammation on metabolic syndrome: a GRADE assessed systematic review and meta-analysis. Journal of Health, Population, and Nutrition, v. 44, n. 1, p. 293, 2025. Disponível em: https://doi.org/10.1186/s41043-025-01039-2.
- YUAN, X. et al. Effect of Intermittent Fasting Diet on Glucose and Lipid Metabolism and Insulin Resistance in Patients with Impaired Glucose and Lipid Metabolism: A Systematic Review and Meta-Analysis. International Journal of Endocrinology, v. 2022, p. 6999907, 2022. Disponível em: https://doi.org/10.1155/2022/6999907.
- KHALAFI, M. et al. Longer-term effects of intermittent fasting on body composition and cardiometabolic health in adults with overweight and obesity: A systematic review and meta-analysis. Obesity Reviews, v. 26, n. 2, p. e13855, 2025. Disponível em: https://doi.org/10.1111/obr.13855.
- WONG, P. S. et al. Effect of 8-Hour Time-Restricted Eating (16/8 TRE) on Glucose Metabolism and Lipid Profile in Adults: A Systematic Review and Meta-Analysis. Nutrition Reviews, v. 84, n. 8, p. 1600–1610, 2026. Disponível em: https://doi.org/10.1093/nutrit/nuaf206.
- VARADY, K. A. et al. Cardiometabolic Benefits of Intermittent Fasting. Annual Review of Nutrition, v. 41, p. 333–361, 2021. Disponível em: https://doi.org/10.1146/annurev-nutr-052020-041327.
- LIU, D. et al. Calorie Restriction with or without Time-Restricted Eating in Weight Loss. The New England Journal of Medicine, v. 386, n. 16, p. 1495–1504, 2022. Disponível em: https://doi.org/10.1056/NEJMoa2114833.
- VARADY, K. A. et al. Clinical application of intermittent fasting for weight loss: progress and future directions. Nature Reviews Endocrinology, v. 18, n. 5, p. 309–321, 2022. Disponível em: https://doi.org/10.1038/s41574-022-00638-x.
- ASSOCIAÇÃO BRASILEIRA PARA O ESTUDO DA OBESIDADE E DA SÍNDROME METABÓLICA (ABESO). Posicionamento brasileiro sobre o tratamento nutricional do sobrepeso e da obesidade. São Paulo: ABESO, 2022.
- RIDDLE, M. C. et al. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. Diabetes Care, v. 44, n. 10, p. 2438–2444, 2021. Disponível em: https://doi.org/10.2337/dci21-0034.
- GREENHILL, C. T2DM remission - consensus on definition. Nature Reviews Endocrinology, v. 17, n. 11, p. 639, 2021. Disponível em: https://doi.org/10.1038/s41574-021-00565-3.
- KANBOUR, S. et al. Impact of bodyweight loss on type 2 diabetes remission: a systematic review and meta-regression analysis of randomised controlled trials. The Lancet Diabetes & Endocrinology, v. 13, n. 4, p. 294–306, 2025. Disponível em: https://doi.org/10.1016/S2213-8587(24)00346-2.
- CHONG, M. Y. et al. Associations of chrono-nutrition with sleep and quality of life: The Maastricht Study. Clinical Nutrition, v. 59, p. 106593, 2026. Disponível em: https://doi.org/10.1016/j.clnu.2026.106593.
